Latest News & Updates
Breaking News
9 hours ago
Vaibhavi M.
Other trending news you may like to read
Novo Nordisk Partners With OpenAI To Accelerate AI-Driven Drug Development, Transform Healthcare with AI Innovation
Novo Nordisk partners with OpenAI to apply AI in drug discovery, clinical development, and operations, accelerating innovation for obesity and diabetes treatments.
Vaibhavi M.
IDEAYA And Servier Report Positive Phase 3 Data For Darovasertib Combo Shows Strong Efficacy In Metastatic Uveal Melanoma Trial
IDEAYA Biosciences reports Phase 3 OptimUM-02 data showing darovasertib plus crizotinib improves PFS and response rates in metastatic uveal melanoma patients.
Vaibhavi M.
ANI Pharmaceuticals Launches Generic Carbamazepine Capsules In $65 Million U.S. Market
ANI Pharmaceuticals launches generic carbamazepine extended-release capsules for epilepsy and mood disorders, expanding CNS portfolio in a $65 million U.S. market.
Vaibhavi M.
Enanta Begins Phase 1 Trial Of EDP-978 Study Of Oral KIT Inhibitor, Targeting Mast Cell-Driven Diseases
Enanta Pharmaceuticals begins Phase 1 trial of EDP-978, its oral KIT inhibitor for urticaria and mast cell-driven diseases, evaluating safety, PK, and PD in healthy volunteers.
Vaibhavi M.
